Alexza Pharmaceuticals ALXA

… Greenberg: Shares of Alexza Pharmaceuticals ( ALXA ) soared to gains of ..... to Tuesday's close. Alexza Pharmaceuticals has seen a great year ..... Product, and Market Upside Alexza Pharmaceuticals is a $75 million company …

Alexza Pharmaceuticals ( ALXA ) Q1 2013 Earnings Call May ..... everyone, and welcome to the Alexza Pharmaceuticals 2013 First Quarter Financial ..... com/article/1435121- alexza - pharmaceuticals -management-discusses …

TEL AVIV, May 8 (Reuters) - Teva Pharmaceutical Industries and Alexza Pharmaceuticals reached an exclusive U.S. license and supply agreement for Adasuve inhalation powder for the treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

Premarket gainers: ALXA +51% . PSE +19% . LEDR +16% . NBG +11% . WFM +8% . EA +6% . PRTS +6% . SFUN +6% . CTSH +5% . Losers: FIO -22 …

Alexza Pharmaceuticals ( ALXA ) comes off trading halt, now up 52% premarket following the license deal with Teva ( TEVA +0.3% premarket). The conference call discussing the matter is underway. Post your comment!

By bsiflingtrades : When analyzing developmental stage bio-tech companies for potential catalyst-driven trades, I look for a number of specific criteria. In this article I will delve into XenoPort ( XNPT ) and present why it may be a perfect candidate for a successful run-up trade. Catalyst and ...

By Markus Aarnio : Product launches are usually major catalysts for stock prices. A product launch can be both a positive catalyst and a negative catalyst for the company's stock price. One example of a positive product launch is Pacira Pharmaceuticals ( PCRX ) with the launch of Exparel in April

Alexza Pharmaceuticals ( ALXA ) is trading higher before the bell after Piper Jaffray upgrades the stock to Overweight from Neutral. Shares +7.3% premarket. Post your comment!